Title : Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics.

Pub. Date : 2020

PMID : 32865790






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics. Fatty Acids albumin Homo sapiens
2 The method introduces fatty acid modifications into the gapmer ASOs design to exploit the binding and transport property of serum albumin for endogenous ligands. Fatty Acids albumin Homo sapiens
3 The level of albumin-gapmer ASOs interaction, blood circulatory half-life and biodistribution was dependent on number, position, and fatty acid type (palmitic or myristic acid) within the gapmer ASO sequence and either phosphorothioate or phosphodiester backbone modifications. Fatty Acids albumin Homo sapiens